AbbVie Shares Fall as Wall Street Focuses on Filler Weakness

AbbVie Inc. forecast 2026 profits above Wall Street’s expectations, though investors saw vulnerabilities in some of the company’s key brands.

Adjusted earnings for the year will be $14.37 to $14.57 a share, AbbVie reported Wednesday. Analysts’ average estimate was for $14.22.

Fourth quarter sales were $16.6 billion, topping forecasts for $16.4 billion, as the company delivered what Chief Executive Officer Rob Michael called “record net sales” for 2025. Quarterly adjusted earnings…